| Cohesin-dependent and-independent mechanisms mediate chromosomal contacts between promoters and enhancers MJ Thiecke, G Wutz, M Muhar, W Tang, S Bevan, V Malysheva, R Stocsits, ... Cell reports 32 (3), 2020 | 123 | 2020 |
| TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation JSY Ho, BWY Mok, L Campisi, T Jordan, S Yildiz, S Parameswaran, ... Cell 184 (10), 2618-2632. e17, 2021 | 83 | 2021 |
| Reconstructed cell fate–regulatory programs in stem cells reveal hierarchies and key factors of neurogenesis MA Mendoza-Parra, V Malysheva, MAM Saleem, M Lieb, A Godel, ... Genome Research 26 (11), 1505-1519, 2016 | 30 | 2016 |
| Chicdiff: a computational pipeline for detecting differential chromosomal interactions in Capture Hi-C data J Cairns, WR Orchard, V Malysheva, M Spivakov Bioinformatics 35 (22), 4764-4766, 2019 | 24 | 2019 |
| Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis V Malysheva, MA Mendoza-Parra, MAM Saleem, H Gronemeyer Genome medicine 8, 1-16, 2016 | 23 | 2016 |
| Detecting chromosomal interactions in Capture Hi-C data with CHiCAGO and companion tools P Freire-Pritchett, H Ray-Jones, M Della Rosa, CQ Eijsbouts, WR Orchard, ... Nature protocols 16 (9), 4144-4176, 2021 | 21 | 2021 |
| Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models JS Yuin Ho, B Wing-Yee Mok, L Campisi, T Jordan, S Yildiz, ... bioRxiv, 2020.12. 01.404483, 2020 | 8 | 2020 |
| A comprehensive resource for retrieving, visualizing, and integrating functional genomics data M Blum, PE Cholley, V Malysheva, S Nicaise, J Moehlin, H Gronemeyer, ... Life science alliance 3 (1), 2020 | 7 | 2020 |
| Gene regulatory network reconstruction incorporating 3D chromosomal architecture reveals key transcription factors and DNA elements driving neural lineage commitment V Malysheva, MA Mendoza-Parra, M Blum, M Spivakov, H Gronemeyer | 6* | 2018 |
| LOGIQA: a database dedicated to long-range genome interactions quality assessment MA Mendoza-Parra, M Blum, V Malysheva, PE Cholley, H Gronemeyer BMC genomics 17, 1-11, 2016 | 6 | 2016 |
| High-resolution promoter interaction analysis in Type 3 Innate Lymphoid Cells implicates Batten Disease gene CLN3 in Crohn’s Disease aetiology V Malysheva, H Ray-Jones, TA Cazares, O Clay, D Ohayon, P Artemov, ... bioRxiv, 2022.10. 19.512842, 2022 | 1 | 2022 |
| Shared and distinct molecular effects of regulatory genetic variants provide insight into mechanisms of distal enhancer-promoter communication H Ray-Jones, Z Song, A Haglund, P Artemov, M Della Rosa, F Burden, ... bioRxiv, 2023.08. 04.551251, 2023 | | 2023 |
| Novel method V Malysheva, S Schoenfelder, M Spivakov, T Nagano, P Fraser US Patent App. 17/656,063, 2022 | | 2022 |
| OP0222 IDENTIFICATION OF CAUSAL GENES AND MECHANISMS BY WHICH GENETIC VARIATION MEDIATES JUVENILE IDIOPATHIC ARTHRITIS SUSCEPTIBILITY USING FUNCTIONAL GENOMICS AND CRISPR-CAS9 A Frantzesko, V Malysheva, C Shi, J Ding, J Bowes, W Thomson, S Eyre, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 146-146, 2022 | | 2022 |
| IDENTIFICATION OF CAUSAL GENES AND MECHANISMS BY WHICH GENETIC VARIATION MEDIATES JUVENILE IDIOPATHIC ARTHRITIS SUSCEPTIBILITY USING FUNCTIONAL GENOMICS AND CRISPR-CAS9 A Frantzeskos, V Malysheva, C Shi, J Ding, J Bowes, W Thomson, S Eyre, ... RHEUMATOLOGY 61, I16-I16, 2022 | | 2022 |
| OA30 Identification of causal genes and mechanisms by which genetic variation mediates juvenile idiopathic arthritis susceptibility using functional genomics and CRISPR-Cas9 A Frantzeskos, V Malysheva, C Shi, J Ding, CLUSTER consortium, ... Rheumatology 61 (Supplement_1), keac132. 030, 2022 | | 2022 |
| Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.(preprint) JSY Ho, BWY Mok, L Campisi, T Jordan, S Yildiz, NN Gaudreault, ... | | 2020 |
| Reconstruction of gene regulatory networks defining the cell fate transition processes V Malysheva Strasbourg, 2016 | | 2016 |
Mikhail SpivakovGroup Leader, Imperial College Institute of Clinical SciencesVerified email at imperial.ac.uk
